Halifax Biomedical Seeking $17M
Flush with the success of its first major installation in the U.S., Halifax Biomedical is out to raise at least $17 million in capital to finance the roll out of six more sites in the next 18 months.
Mabou-based Halifax Biomedical has retained Precipice Capital of Dartmouth to arrange the funding, which it hopes will comprise at least $10 million in equity financing and $7 million in debt. It plans to close the round by June.
“It would be seen as an appropriate raise for the type of work we’re doing,” said CEO Chad Munro in an interview Wednesday.
The size of the fund will require